A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s10637-014-0139-9
Published Online: 2014-07-19
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chu, Quincy S.
Sangha, Randeep
Hotte, Sebastien J.
Sergenson, Gwen
Schnell, David
Chand, Vikram K.
Hirte, Hal W.
Text and Data Mining valid from 2014-07-19
Version of Record valid from 2014-07-19
Article History
Received: 9 June 2014
Accepted: 15 July 2014
First Online: 19 July 2014